Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Nanobiotechnology
|
July 25, 2003
Combinatorial peptidomics: a generic approach for protein expression profiling
Mikhail Soloviev, Richard Barry, Elaine Scrivener, et al.
Journal of Biomolecular Screening
|
July 15, 2003
Competitive assay formats for high-throughput affinity arrays
Richard Barry, Tricia Diggle, Jonathan Terrett, et al.
Proteomics
|
February 26, 2003
Peptidomics: A new approach to affinity protein microarrays
Elaine Scrivener, Richard Barry, Albert Platt, et al.
Molecular Cancer Therapeutics
|
June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors
Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Molecular Cancer Therapeutics
|
June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage, et al.
Blood Advances
|
May 5, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma
Joseph P McGuirk, Armin Ghobadi, Carlos R Bachier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Nanobiotechnology
|
July 25, 2003
Combinatorial peptidomics: a generic approach for protein expression profiling
Mikhail Soloviev, Richard Barry, Elaine Scrivener, et al.
Journal of Biomolecular Screening
|
July 15, 2003
Competitive assay formats for high-throughput affinity arrays
Richard Barry, Tricia Diggle, Jonathan Terrett, et al.
Proteomics
|
February 26, 2003
Peptidomics: A new approach to affinity protein microarrays
Elaine Scrivener, Richard Barry, Albert Platt, et al.
Molecular Cancer Therapeutics
|
June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors
Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Molecular Cancer Therapeutics
|
June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage, et al.
Blood Advances
|
May 5, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma
Joseph P McGuirk, Armin Ghobadi, Carlos R Bachier, et al.
Page
of 1